Verenium Corp.
Cambridge, MA 02142
Share:
Verenium and Bunge Sign New Agreement to Develop and Commercialize Enzymes for Enhanced Production of Edible Oils
Builds on successful track record CAMBRIDGE, Mass. and ST. LOUIS, Jan. 7 - Verenium Corporation (NASDAQ:VRNM), a pioneer in the development of high performance specialty enzymes and a leading developer of cellulosic ethanol technology, and Bunge Oils, Inc., a part of Bunge North America, the North American operating arm of Bunge Limited (NYSE:BG), announced today that they have signed a new...
Read More »Verenium to Present at Jefferies 11th Global Clean Technology Conference
SAN DIEGO, Feb. 16, 2011 - Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that James Levine, Executive Vice President and Chief Financial Officer, will present at the upcoming Jefferies 11th Global Clean Technology Conference. The presentation is scheduled to begin at 1:30 p.m. EST on...
Read More »Verenium to Present at Baird's 2010 Clean Technology Conference
CAMBRIDGE, Mass., Nov. 23, 2010 -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions,today announced that James Levine, Executive Vice President and Chief Financial Officer, will present at the upcoming Baird 2010 Clean Technology Conference. The presentation is scheduled to begin at 10:00 a.m. PST on Wednesday,...
Read More »Verenium Announces Collaboration with Edible Oil Leader Desmet Ballestra
Agreement with second global engineering partner further extends PurifineÃ-® PLC potential market reach CAMBRIDGE, Mass., Nov. 23, 2010 -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering...
Read More »Verenium to Present at Jefferies 10th Global Clean Technology Conference
CAMBRIDGE, Mass., Nov. 9, 2010 - Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that Janet Roemer, President and Chief Operating Officer, will present at the upcoming Jefferies 10th Global Clean Technology Conference. The presentation is scheduled to begin at 3:45 p.m. GMT on Tuesday,...
Read More »Verenium Closes Sale of Cellulosic Biofuels Business to BP
Company to focus on growing commercial enzyme business CAMBRIDGE, Mass., Sept. 2 -- Verenium Corporation (NASDAQ: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced the closing of the sale of its cellulosic biofuels business to BP Biofuels North America for $98.3 million, subject to the additional financial terms of the...
Read More »Verenium Corporation to Present at the BIO CEO & Investor Conference
CAMBRIDGE, Mass., Feb. 6 - Verenium Corporation (NASDAQ:VRNM), a leading developer of cellulosic ethanol technology and a pioneer in the development of high-performance specialty enzymes, announced today that William H. Baum, Verenium's Executive Vice President, Business Development and General Manager, Specialty Enzyme Business Unit, will present at the upcoming BIO CEO & Investor Conference....
Read More »Verenium Corporation to Present at the Credit Suisse Energy Summit
CAMBRIDGE, Mass., Jan. 31 -- Verenium Corporation (NASDAQ:VRNM), a leading developer of cellulosic ethanol technology and a pioneer in the development of high-performance specialty enzymes, announced today that Carlos A. Riva, Verenium's President and Chief Executive Officer, will present at the upcoming Credit Suisse Energy Summit. The presentation is scheduled to begin at 10:05 a.m. MT on...
Read More »Verenium and Bunge Sign New Agreement to Develop and Commercialize Enzymes for Enhanced Production of Edible Oils
Builds on successful track record CAMBRIDGE, Mass. and ST. LOUIS, Jan. 7 - Verenium Corporation (NASDAQ:VRNM), a pioneer in the development of high performance specialty enzymes and a leading developer of cellulosic ethanol technology, and Bunge Oils, Inc., a part of Bunge North America, the North American operating arm of Bunge Limited (NYSE:BG), announced today that they have signed a new...
Read More »